scorecardresearch
Add as a preferred source on Google
Wednesday, January 28, 2026
TopicCarcinogen

Topic: Carcinogen

All about hepatitis D, deadly viral hepatitis given a ‘cancer’ tag by WHO

Hepatitis D or HDV, which only affects individuals infected with hepatitis B, is associated with a two- to six-fold higher risk of liver cancer compared to hepatitis B alone.

US has dealt final blow to asbestos. But this carcinogen is still widely used in India

India accounted for nearly half of global asbestos imports in 2021. While India banned asbestos mining in 1993, there is no law to restrict its use in construction, import or trade.

Aspartame is as carcinogenic as aloe vera leaves or exhaust fumes. No reason for concern yet

Regulators agree that it’s safe for a person to consume about 2.8g for a 70kg adult, which is much more than most people consume.

Do diet colas pose cancer risk? What doctors say on ‘possible carcinogen’ tag for sweetener aspartame

The popular artificial sweetener aspartame is expected to be classified as a possible carcinogen by WHO’s International Agency for Research in Cancer. Report to come on 14 July.

Ranitidine off essential meds list but India still sells ‘cancer-causing’ antacid shunned by world

Known as Rantac and Zantac in India, ranitidine is still a heartburn go-to. But several countries suspended its sale in 2020 after it was found to contain cancer-causing compound.

Diabetes drug metformin latest to be targeted for carcinogen scrutiny

US FDA says it is testing samples of metformin sold in the US for NDMA, and that it will recommend recalls of the medication as appropriate.

Fourth carcinogen discovered in blood-pressure pills used by millions

Some valsartan found positive for carcinogen DMF by US online pharmacy Valisure include those made by Indian pharma firms Alembic and Macleods.

European regulator finds cancer-causing element in diabetes medicines made in India

European Medicines Agency tells Hyderabad-based Hetero Labs to test its diabetes medicine pioglitazone for “low levels” of cancer-causing substance in them.

On Camera

Most EU firms eye India expansion post-trade deal, 90% say profitability to go up—FEBI survey

FEBI survey reveals Europe’s big bet on manufacturing, innovation hub amid ‘mother of all trade deals’, but flags regulatory concerns.

India, EU sign security & defence pact. How it links Indian firms to ‘ReArm Europe’ network 

The agreement comes despite differences between India and the EU on issues such as Russia-Ukraine war, showcasing the intent to deepen strategic ties. 

Non-alignment is coming back in a new avatar: Trump-peedit alliance

No nation other than China can negotiate one-on-one with Trump on an equal footing. That’s why the middle powers who so far formed the core of multilateral bodies now feel orphaned.